Table 1 Clinical Characteristics of Study Participants
From: Pathomorphological characteristics of tuberculous placenta and its clinical implication
Case No. | Age | History of TB | Pregnancy information | CT diagnosis | Sputum result | Pathogenetic examination | Pregnancy outcome | Weeks of gestation* | Mode of delivery | Anti-TB treatment | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 28 | N | Twin, IVF | Subacute hematogenous pulmonary TB | Smear+ | AFB+, PCR+, T-spot+ | Intrauterine stillbirth | 27 | Induced labour abortion | HREMfx | |
2 | 30 | Y | Single fetus, IVF | Obsolete pulmonary TB | Smear+ | AFB+, PCR+ | Intrauterine stillbirth | 21 | Spontaneous abortion | HRE | |
3 | 31 | N | Single fetus, spontaneous pregnancy | Acute miliary hematogenous disseminated pulmonary TB | Smear+, culture+ | AFB+, PCR+, T-spot+ | Intrauterine stillbirth | 13 | Induced labour abortion | HRZ | |
4 | 39 | Y | Single fetus, IVF | Acute miliary hematogenous disseminated pulmonary TB | Smear+ | AFB+, PCR+, T-spot+ | Surviving, mild intrauterine asphyxia | 38 | Cesarean | HRE | Infant with congenital TB |
5 | 26 | Y | Single fetus, spontaneous pregnancy | Pulmonary TB | Smear+ | AFB+, PCR+ | Surviving | 38 | Cesarean | HREZ | |
6 | 32 | N | Single fetus, IVF | Bilateral miliary hematogenous disseminated pulmonary TB | Smear+ | AFB+, PCR+, T-spot+ | Artificial abortion | 21 | Induced labour abortion | HRE | |
7 | 33 | N | Twin, IVF | Chronic pulmonary hematogenous disseminated TB | Smear+, culture+ | AFB+, PCR+, T-spot+ | Surviving, low-weight preterm infants | 27 | Natural labour | HRZ | One of the twins with congenital TB |
8 | 30 | N | Single fetus, spontaneous pregnancy | Bilateral pulmonary hematogenous disseminated TB | Smear+ | AFB+, PCR+, T-spot+ | Surviving, low-weight preterm infant | 32 | Cesarean | HREZ | |
9 | 27 | Y | Single fetus, IVF | Acute hematogenous disseminated pulmonary TB | Smear+ | AFB+, PCR+ | Intrauterine stillbirth | 24 | Spontaneous abortion | HRE | |
10 | 40 | N | Single fetus, IVF | Bilateral hematogenous disseminated pulmonary TB | Smear+ | AFB+, PCR+ | Artificial abortion | 19 | Induced labour abortion | HREZ | |
11 | 27 | N | Single fetus, spontaneous pregnancy | Bilateral hematogenous disseminated pulmonary TB | Smear+ | AFB+, PCR+ | Intrauterine stillbirth | 26 | Induced labour abortion | HRMfx + linezolid | |
12 | 22 | Y | Single fetus, spontaneous pregnancy | Bilateral miliary hematogenous disseminated pulmonary TB | Smear+ | AFB+, PCR+, T-spot+ | Surviving | 31 | Natural labour | HREZ | |
13 | 36 | U | Single fetus, IVF | N/A | Smear+ | AFB+, PCR+, T-spot+ | Surviving | 36 | Cesarean | HRZE | |
14 | 35 | U | Single fetus, spontaneous pregnancy | Bilateral acute hematogenous pulmonary TB | Smear+ | AFB+, PCR+ | Artificial abortion | 16 | Induced labour abortion | HREMfx + amikacin + meropenem | |
15 | 28 | Y | Single fetus, spontaneous pregnancy | N/A | Smear+ | AFB+, PCR+ | Surviving | 39 | Cesarean | U | |
16 | 39 | Y | Single fetus, spontaneous pregnancy | N/A | Smear+ | AFB+, PCR+ | Intrauterine stillbirth | 19 | Induced labour abortion | HRE | |
17 | 31 | Y | Single fetus, spontaneous pregnancy | Chronic inflammation | Smear+ | AFB+, PCR+ | Surviving | 38 | Cesarean | HRZE | |
18 | 29 | Y | Single fetus, IVF | Pulmonary TB | Smear+ | AFB+, PCR+ | Surviving, low-weight preterm infant | 31 | Cesarean | HREZ | Infant with congenital TB |
19 | 36 | N | Single fetus, spontaneous pregnancy | Acute hematogenous pulmonary TB | Smear+ | AFB+, PCR+ | Intrauterine stillbirth | 20 | Induced labour abortion | HREZ |